{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:16:45Z","timestamp":1785367005497,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ccc.2020.08.004","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:24:46Z","timestamp":1604017486000},"page":"85-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Oncologic Emergencies"],"prefix":"10.1016","volume":"37","author":[{"given":"Jenna","family":"Spring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laveena","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCM.0b013e3181c0349e","article-title":"Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study","volume":"38","author":"Soares","year":"2010","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2020.08.004_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.blre.2012.01.003","article-title":"Hyperleukocytosis, leukostasis and leukapheresis: practice management","volume":"26","author":"Ganzel","year":"2012","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ejh.13073","article-title":"Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients","volume":"101","author":"Tien","year":"2018","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.ccc.2020.08.004_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/10428194.2020.1728753","article-title":"Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy","volume":"61","author":"Shallis","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ccc.2020.08.004_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-020-0783-3","article-title":"Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study","author":"Stahl","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ccc.2020.08.004_bib6","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the Seventh Special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J\u00a0Clin Apher"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/cells8010066","article-title":"Adhesion deregulation in acute myeloid leukaemia","volume":"8","author":"Gruszka","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17474086.2017.1270754","article-title":"Hyperleukocytosis and leukostasis: management of a medical emergency","volume":"10","author":"Giammarco","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajh.2830400106","article-title":"Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases","volume":"40","author":"Soares","year":"1992","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.ccc.2020.08.004_bib10","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(20011101)92:9<2237::AID-CNCR1569>3.0.CO;2-9","article-title":"Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature","volume":"92","author":"Sillos","year":"2001","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ccc.2020.08.004_bib11","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3109\/10428194.2016.1142083","article-title":"Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia","volume":"57","author":"Mamez","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/trf.14329","article-title":"The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study","volume":"58","author":"Choi","year":"2018","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.transci.2018.02.006","article-title":"The management of hyperleukocytosis in 2017: do we still need leukapheresis?","volume":"57","author":"Korkmaz","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.ccc.2020.08.004_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bjh.13189","article-title":"Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis","volume":"168","author":"Daver","year":"2015","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ccc.2020.08.004_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0030-1254048","article-title":"Disseminated intravascular coagulation in hematologic malignancies","volume":"36","author":"Franchini","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.ccc.2020.08.004_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-2001-18865","article-title":"Disseminated intravascular coagulation in acute leukemia","volume":"27","author":"Barbui","year":"2001","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.ccc.2020.08.004_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11864-004-0015-5","article-title":"Waldenstrom macroglobulinemia","volume":"5","author":"Ghobrial","year":"2004","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"10.1016\/j.ccc.2020.08.004_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-2003-44554","article-title":"Hyperviscosity syndrome in plasma cell dyscrasias","volume":"29","author":"Mehta","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(85)90540-6","article-title":"Evaluation of hyperviscosity in monoclonal gammopathies","volume":"79","author":"Crawford","year":"1985","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.ccc.2020.08.004_bib20","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2011-04-347690","article-title":"Evidence-based focused review of management of hyperviscosity syndrome","volume":"119","author":"Stone","year":"2012","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.ccc.2020.08.004_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2018-06-846816","article-title":"Acute hyperviscosity: syndromes and management","volume":"132","author":"Gertz","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bjh.14196","article-title":"Recommendations for the diagnosis and initial evaluation of patients with Waldenstrom macroglobulinaemia: a task force from the 8th International Workshop on Waldenstrom Macroglobulinaemia","volume":"175","author":"Castillo","year":"2016","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ccc.2020.08.004_bib23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00134-018-5087-y","article-title":"Hyperviscosity syndrome","volume":"44","author":"Dumas","year":"2018","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ccc.2020.08.004_bib24","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2014-03-565135","article-title":"Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus","volume":"124","author":"Dimopoulos","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ccc.2020.08.004_bib25","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/1097-0142(19900315)65:6<1456::AID-CNCR2820650634>3.0.CO;2-5","article-title":"Cardiac metastases","volume":"65","author":"Klatt","year":"1990","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ccc.2020.08.004_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMra022643","article-title":"Acute cardiac tamponade","volume":"349","author":"Spodick","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"42","key":"10.1016\/j.ccc.2020.08.004_bib27","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccc.2020.08.004_bib28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1148\/rg.276065002","article-title":"Imaging findings in cardiac tamponade with emphasis on CT","volume":"27","author":"Restrepo","year":"2007","journal-title":"Radiographics"},{"issue":"16","key":"10.1016\/j.ccc.2020.08.004_bib29","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1001\/jama.297.16.1810","article-title":"Does this patient with a pericardial effusion have cardiac tamponade?","volume":"297","author":"Roy","year":"2007","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccc.2020.08.004_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.echo.2013.06.023","article-title":"American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography","volume":"26","author":"Klein","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.ccc.2020.08.004_bib31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.70.6.966","article-title":"Right ventricular and right atrial collapse in patients with cardiac tamponade--a combined echocardiographic and hemodynamic study","volume":"70","author":"Singh","year":"1984","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccc.2020.08.004_bib32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjcard.2018.06.002","article-title":"Safety and outcome of percutaneous drainage of pericardial effusions in patients with cancer","volume":"122","author":"Lekhakul","year":"2018","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ccc.2020.08.004_bib33","first-page":"1126","article-title":"2015 ESC guidelines for the diagnosis and management of pericardial diseases","volume":"68","author":"Adler","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"10","key":"10.1016\/j.ccc.2020.08.004_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11886-018-1040-5","article-title":"Pericardial disease associated with malignancy","volume":"20","author":"Schusler","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"18","key":"10.1016\/j.ccc.2020.08.004_bib35","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMcp067190","article-title":"Clinical practice. Superior vena cava syndrome with malignant causes","volume":"356","author":"Wilson","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccc.2020.08.004_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-0037-1608863","article-title":"Malignant venous obstruction: superior vena cava syndrome and beyond","volume":"34","author":"Friedman","year":"2017","journal-title":"Semin Intervent Radiol"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0169-5002(03)00361-1","article-title":"Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer","volume":"43","author":"Urruticoechea","year":"2004","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2214\/AJR.08.1904","article-title":"Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome","volume":"193","author":"Lanciego","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.carj.2012.09.003","article-title":"Superior vena cava syndrome: role of the interventionalist","volume":"65","author":"Rachapalli","year":"2014","journal-title":"Can Assoc Radiol J"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0970-9185.94910","article-title":"Anesthetic management of superior vena cava syndrome due to anterior mediastinal mass","volume":"28","author":"Chaudhary","year":"2012","journal-title":"J\u00a0Anaesthesiol Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1213\/ANE.0b013e31821f9c95","article-title":"Airway collapse with an anterior mediastinal mass despite spontaneous ventilation in an adult","volume":"113","author":"Gardner","year":"2011","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.ccc.2020.08.004_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2044.1999.00961.x","article-title":"Anterior mediastinal masses: an anaesthetic challenge","volume":"54","author":"Goh","year":"1999","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.ajkd.2011.08.029","article-title":"Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes","volume":"59","author":"Doshi","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"10.1016\/j.ccc.2020.08.004_bib44","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis","volume":"356","author":"Ellison","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccc.2020.08.004_bib45","first-page":"1056","article-title":"The hyponatremic patient: a systematic approach to laboratory diagnosis","volume":"166","author":"Milionis","year":"2002","journal-title":"CMAJ"},{"issue":"10 Suppl 1","key":"10.1016\/j.ccc.2020.08.004_bib46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ccc.2020.08.004_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00134-014-3210-2","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"40","author":"Spasovski","year":"2014","journal-title":"Intensive Care Med"},{"issue":"1\u20132","key":"10.1016\/j.ccc.2020.08.004_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01402610","article-title":"Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression","volume":"107","author":"Bach","year":"1990","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.49.2.452","article-title":"Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach","volume":"49","author":"Schiff","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ccc.2020.08.004_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-2004-861532","article-title":"Metastatic spinal cord compression by solid tumors","volume":"24","author":"Gabriel","year":"2004","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.ccc.2020.08.004_bib51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0959-8049(94)90263-1","article-title":"Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients","volume":"30A","author":"Helweg-Larsen","year":"1994","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ccc.2020.08.004_bib52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/clon.2002.0098","article-title":"Don't wait for a sensory level--listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression","volume":"14","author":"Levack","year":"2002","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1200\/JCO.2018.78.1211","article-title":"Assessment and management of patients with metastatic spinal cord compression: a multidisciplinary review","volume":"37","author":"Lawton","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ccc.2020.08.004_bib54","unstructured":"In: 2019 surveillance of metastatic spinal cord compression in adults: risk assessment, diagnosis and management (NICE guideline CG75). London: National Institute for Health and Care Excellence; 2019."},{"key":"10.1016\/j.ccc.2020.08.004_bib55","doi-asserted-by":"crossref","first-page":"i2539","DOI":"10.1136\/bmj.i2539","article-title":"Metastatic spinal cord compression: diagnosis and management","volume":"353","author":"Al-Qurainy","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ccc.2020.08.004_bib56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1017\/cjn.2016.255","article-title":"The influence of corticosteroids on diagnostic accuracy of biopsy for primary central nervous system lymphoma","volume":"43","author":"Binnahil","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"19","key":"10.1016\/j.ccc.2020.08.004_bib57","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccc.2020.08.004_bib58","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1634\/theoncologist.2017-0147","article-title":"In-hospital outcomes of tumor lysis syndrome: a population-based study using the National Inpatient Sample","volume":"22","author":"Durani","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.ccc.2020.08.004_bib59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ccc.2020.08.004_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12415","article-title":"Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Reanimation Respiratoire et Onco-Hematologique","volume":"162","author":"Darmon","year":"2013","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.ccc.2020.08.004_bib61","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.amjmed.2003.09.045","article-title":"Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome","volume":"116","author":"Davidson","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ccc.2020.08.004_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00277-015-2585-7","article-title":"Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review","volume":"95","author":"Howard","year":"2016","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.ccc.2020.08.004_bib63","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.ccc.2020.08.004_bib65","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.13403","article-title":"Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology","volume":"169","author":"Jones","year":"2015","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474086.2016.1127156","article-title":"Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency","volume":"9","author":"Criscuolo","year":"2016","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10.1016\/j.ccc.2020.08.004_bib67","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2013.02.378","article-title":"Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis","volume":"62","author":"Lopez-Olivo","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","article-title":"Tumor lysis syndrome: new challenges and recent advances","volume":"21","author":"Wilson","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"10.1016\/j.ccc.2020.08.004_bib69","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ccc.2020.08.004_bib70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14694\/EdBook_AM.2015.35.76","article-title":"Managing immune checkpoint-blocking antibody side effects","volume":"35","author":"Postow","year":"2015","journal-title":"American Society of Clinical Oncology Educational Book"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1634\/theoncologist.2018-0045","article-title":"Strategies for recognizing and managing immune-mediated adverse events in the treatment of Hodgkin lymphoma with checkpoint inhibitors","volume":"24","author":"Vardhana","year":"2019","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40264-018-0774-8","article-title":"Safety and tolerability of immune checkpoint inhibitors (PD-1 and PD-L1) in cancer","volume":"42","author":"Baraibar","year":"2019","journal-title":"Drug Saf"},{"issue":"17","key":"10.1016\/j.ccc.2020.08.004_bib73","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ccc.2020.08.004_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.ccc.2020.08.004_bib75","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol Ther Oncolytics"},{"issue":"26","key":"10.1016\/j.ccc.2020.08.004_bib76","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T\u00a0cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ccc.2020.08.004_bib77","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T\u00a0cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ccc.2020.08.004_bib78","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1097\/HS9.0000000000000191","article-title":"In the eye of the storm: immune-mediated toxicities associated with CAR-T cell therapy","volume":"3","author":"Garcia Borrega","year":"2019","journal-title":"Hemasphere"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070420300579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070420300579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:07:37Z","timestamp":1760062057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070420300579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0749070420300579"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2020.08.004","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncologic Emergencies","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2020.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}